Last reviewed · How we verify
Tromethamol Glucaldrate (aloglutamol)
Tromethamol Glucaldrate (generic name: aloglutamol) is a aloglutamol drug. It is currently in unknown development.
Tromethamine Gluconate is thought to work by interacting with specific biological molecules to produce its therapeutic effect.
Tromethamine Gluconate is not mentioned in the provided facts, so I will use the information about Aloglutamol. Aloglutamol, also known as Altris, Pyreses, Tasto, and Sabro, is an antacid that is an aluminium compound, typically given orally in doses of 0.5 to 1 g. It is a salt of aluminium, gluconic acid, and tris.
At a glance
| Generic name | aloglutamol |
|---|---|
| Drug class | aloglutamol |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like a city, and Tromethamine Gluconate is a special key that unlocks a specific door to help restore balance and function. However, the exact door it unlocks and how it does so is not yet fully understood. More research is needed to determine how it works and what it does.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tromethamol Glucaldrate CI brief — competitive landscape report
- Tromethamol Glucaldrate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Tromethamol Glucaldrate
What is Tromethamol Glucaldrate?
How does Tromethamol Glucaldrate work?
What is the generic name of Tromethamol Glucaldrate?
What drug class is Tromethamol Glucaldrate in?
What development phase is Tromethamol Glucaldrate in?
Related
- Drug class: All aloglutamol drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing